25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

001540 (Ahn-gook) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ahn-gook together

I guess you are interested in Ahn-Gook Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Ahn-gook’s Financial Insights
  • 📈 Technical Analysis (TA) – Ahn-gook’s Price Targets

I'm going to help you getting a better view of Ahn-Gook Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ahn-Gook Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Ahn-Gook Pharmaceutical Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Ahn-gook (30 sec.)










1.2. What can you expect buying and holding a share of Ahn-gook? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
70.0%

What is your share worth?

Current worth
₩14,235.00
Expected worth in 1 year
₩14,694.62
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
₩459.62
Return On Investment
5.7%

For what price can you sell your share?

Current Price per Share
₩8,000.00
Expected price per share
₩7,108 - ₩8,280
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ahn-gook (5 min.)




Live pricePrice per Share (EOD)
₩8,000.00

2.2. Growth of Ahn-gook (5 min.)




Is Ahn-gook growing?

Current yearPrevious yearGrowGrow %
How rich?$113.2m$108m$7.1m6.2%

How much money is Ahn-gook making?

Current yearPrevious yearGrowGrow %
Making money$2.2m$1.1m$1m49.3%
Net Profit Margin4.6%2.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Ahn-gook (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ahn-gook?

Welcome investor! Ahn-gook's management wants to use your money to grow the business. In return you get a share of Ahn-gook.

First you should know what it really means to hold a share of Ahn-gook. And how you can make/lose money.

Speculation

The Price per Share of Ahn-gook is ₩8,000. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ahn-gook.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ahn-gook, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩14,235.00. Based on the TTM, the Book Value Change Per Share is ₩114.90 per quarter. Based on the YOY, the Book Value Change Per Share is ₩43.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ahn-gook.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.220.0%0.190.0%0.100.0%0.140.0%0.090.0%0.100.0%
Usd Book Value Change Per Share-0.180.0%0.080.0%0.030.0%0.100.0%0.040.0%0.060.0%
Usd Dividend Per Share0.000.0%0.000.0%0.040.0%0.050.0%0.060.0%0.080.0%
Usd Total Gains Per Share-0.180.0%0.080.0%0.070.0%0.150.0%0.110.0%0.140.0%
Usd Price Per Share4.44-4.80-5.88-5.45-6.81-8.40-
Price to Earnings Ratio5.02--36.04-15.18--0.21-13.96-18.35-
Price-to-Total Gains Ratio-24.37--62.92--27.54--59.10--32.45-70.47-
Price to Book Ratio0.45-0.47-0.62-0.57-0.74-0.97-
Price-to-Total Gains Ratio-24.37--62.92--27.54--59.10--32.45-70.47-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.6
Number of shares178
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.06
Usd Book Value Change Per Share0.080.04
Usd Total Gains Per Share0.080.11
Gains per Quarter (178 shares)14.3218.79
Gains per Year (178 shares)57.2775.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105747443165
201151048961140
3017216113392215
40229218178123290
50286275222153365
60344332267184440
70401389311215515
80458446356245590
90515503400276665
100573560445307740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%9.03.00.075.0%15.05.00.075.0%31.07.02.077.5%37.07.05.075.5%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%8.012.00.040.0%23.017.00.057.5%30.019.00.061.2%
Dividend per Share0.00.04.00.0%4.00.08.033.3%11.00.09.055.0%28.00.012.070.0%34.00.015.069.4%
Total Gains per Share1.03.00.025.0%6.06.00.050.0%10.010.00.050.0%27.013.00.067.5%35.014.00.071.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ahn-Gook Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---260.169114.904-326%43.409-699%137.745-289%61.564-523%85.995-403%
Book Value Per Share--14235.00414478.061-2%13585.199+5%13818.782+3%13312.577+7%12638.274+13%
Current Ratio--1.6951.736-2%1.759-4%1.851-8%2.101-19%1.850-8%
Debt To Asset Ratio--0.4690.458+2%0.372+26%0.378+24%0.346+35%0.332+41%
Debt To Equity Ratio--0.8770.841+4%0.612+43%0.631+39%0.549+60%0.508+72%
Dividend Per Share----0%55.000-100%73.570-100%89.226-100%114.146-100%
Enterprise Value---70637556000.000-61032533005.000-14%9321081122.500-858%3503269353.333-2116%56879814567.000-224%84315915304.000-184%
Eps--315.469277.860+14%140.909+124%200.435+57%127.198+148%141.870+122%
Ev To Sales Ratio---0.233-0.216-7%0.045-619%0.040-677%0.382-161%0.508-146%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.950+5%
Market Cap90923200000.000+21%72056636000.00077909817000.000-8%95440946500.000-25%88479639000.000-19%110964349850.000-35%137443966125.000-48%
Net Profit Margin--0.0470.046+4%0.025+90%0.036+30%0.023+105%0.031+51%
Operating Margin----0%-0%0.018-100%0.007-100%0.017-100%
Operating Ratio--0.7251.198-39%1.244-42%0.879-18%0.686+6%0.861-16%
Pb Ratio0.562+21%0.4450.473-6%0.619-28%0.566-21%0.742-40%0.974-54%
Pe Ratio6.340+21%5.024-36.042+817%15.181-67%-0.213+104%13.955-64%18.352-73%
Price Per Share8000.000+21%6340.0006855.000-8%8397.500-25%7785.000-19%9726.000-35%11994.000-47%
Price To Free Cash Flow Ratio----0.5310%51.338-100%14.557-100%6.219-100%0.462-100%
Price To Total Gains Ratio-30.749-26%-24.369-62.924+158%-27.543+13%-59.097+143%-32.449+33%70.473-135%
Quick Ratio---0.709-100%1.142-100%1.234-100%1.768-100%1.665-100%
Return On Assets--0.0120.010+13%0.005+134%0.008+42%0.005+120%0.007+63%
Return On Equity--0.0220.019+15%0.010+118%0.014+55%0.009+143%0.011+98%
Total Gains Per Share---260.169114.904-326%98.409-364%211.315-223%150.790-273%200.140-230%
Usd Book Value--113250563.300115184269.340-2%108080858.123+5%109939191.005+3%106201812.530+7%101282912.689+12%
Usd Book Value Change Per Share---0.1820.080-326%0.030-699%0.096-289%0.043-523%0.060-403%
Usd Book Value Per Share--9.96510.135-2%9.510+5%9.673+3%9.319+7%8.847+13%
Usd Dividend Per Share----0%0.038-100%0.051-100%0.062-100%0.080-100%
Usd Enterprise Value---49446289.200-42722773.104-14%6524756.786-858%2452288.547-2116%39815870.197-224%59021140.713-184%
Usd Eps--0.2210.195+14%0.099+124%0.140+57%0.089+148%0.099+122%
Usd Free Cash Flow---836231.284-100%-14984512.5200%-4522634.0380%-3622606.0810%188594.852-100%
Usd Market Cap63646240.000+21%50439645.20054536871.900-8%66808662.550-25%61935747.300-19%77675044.895-35%96210776.288-48%
Usd Price Per Share5.600+21%4.4384.799-8%5.878-25%5.450-19%6.808-35%8.396-47%
Usd Profit--2509799.6002210593.576+14%1121038.772+124%1594617.773+57%1011807.109+148%1139662.740+120%
Usd Revenue--53026225.70049197468.180+8%42738983.355+24%43094622.055+23%36926899.443+44%34032180.562+56%
Usd Total Gains Per Share---0.1820.080-326%0.069-364%0.148-223%0.106-273%0.140-230%
 EOD+3 -4MRQTTM+11 -19YOY+16 -163Y+15 -185Y+15 -1810Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of Ahn-Gook Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.340
Price to Book Ratio (EOD)Between0-10.562
Net Profit Margin (MRQ)Greater than00.047
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.695
Debt to Asset Ratio (MRQ)Less than10.469
Debt to Equity Ratio (MRQ)Less than10.877
Return on Equity (MRQ)Greater than0.150.022
Return on Assets (MRQ)Greater than0.050.012
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Ahn-Gook Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.644
Ma 20Greater thanMa 507,969.500
Ma 50Greater thanMa 1007,524.200
Ma 100Greater thanMa 2007,030.100
OpenGreater thanClose8,080.000
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Ahn-Gook Pharmaceutical Co. Ltd

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2025-06-22 07:45:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ahn-gook earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.7% means that ₩0.05 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 4.7%. The company is making a profit. +1
  • The TTM is 4.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.7%TTM4.6%+0.2%
TTM4.6%YOY2.5%+2.1%
TTM4.6%5Y2.3%+2.2%
5Y2.3%10Y3.1%-0.8%
4.3.1.2. Return on Assets

Shows how efficient Ahn-gook is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.2% Return on Assets means that Ahn-gook generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.0%+0.1%
TTM1.0%YOY0.5%+0.5%
TTM1.0%5Y0.5%+0.5%
5Y0.5%10Y0.7%-0.2%
4.3.1.3. Return on Equity

Shows how efficient Ahn-gook is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.2% Return on Equity means Ahn-gook generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 2.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.2%TTM1.9%+0.3%
TTM1.9%YOY1.0%+0.9%
TTM1.9%5Y0.9%+1.0%
5Y0.9%10Y1.1%-0.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ahn-Gook Pharmaceutical Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ahn-gook is operating .

  • Measures how much profit Ahn-gook makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.7%-0.7%
5Y0.7%10Y1.7%-1.0%
4.3.2.2. Operating Ratio

Measures how efficient Ahn-gook is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.72 means that the operating costs are ₩0.72 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.725. The company is efficient in keeping operating costs low. +1
  • The TTM is 1.198. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.725TTM1.198-0.473
TTM1.198YOY1.244-0.046
TTM1.1985Y0.686+0.512
5Y0.68610Y0.861-0.175
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ahn-Gook Pharmaceutical Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ahn-gook is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.69 means the company has ₩1.69 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 1.695. The company is able to pay all its short-term debts. +1
  • The TTM is 1.736. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.695TTM1.736-0.041
TTM1.736YOY1.759-0.024
TTM1.7365Y2.101-0.366
5Y2.10110Y1.850+0.252
4.4.3.2. Quick Ratio

Measures if Ahn-gook is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.709-0.709
TTM0.709YOY1.142-0.432
TTM0.7095Y1.768-1.058
5Y1.76810Y1.665+0.103
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ahn-Gook Pharmaceutical Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ahn-gook assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ahn-gook to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Ahn-gook assets are financed with 46.9% credit (debt) and the remaining percentage (100% - 46.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.469. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.458. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.469TTM0.458+0.011
TTM0.458YOY0.372+0.086
TTM0.4585Y0.346+0.111
5Y0.34610Y0.332+0.015
4.5.4.2. Debt to Equity Ratio

Measures if Ahn-gook is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 87.7% means that company has ₩0.88 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.877. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.841. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.877TTM0.841+0.036
TTM0.841YOY0.612+0.229
TTM0.8415Y0.549+0.292
5Y0.54910Y0.508+0.041
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Ahn-gook generates.

  • Above 15 is considered overpriced but always compare Ahn-gook to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 5.02 means the investor is paying ₩5.02 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The EOD is 6.340. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.024. Based on the earnings, the company is cheap. +2
  • The TTM is -36.042. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.340MRQ5.024+1.316
MRQ5.024TTM-36.042+41.066
TTM-36.042YOY15.181-51.223
TTM-36.0425Y13.955-49.997
5Y13.95510Y18.352-4.397
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.531+0.531
TTM-0.531YOY51.338-51.869
TTM-0.5315Y6.219-6.751
5Y6.21910Y0.462+5.757
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ahn-gook is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.45 means the investor is paying ₩0.45 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The EOD is 0.562. Based on the equity, the company is cheap. +2
  • The MRQ is 0.445. Based on the equity, the company is cheap. +2
  • The TTM is 0.473. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.562MRQ0.445+0.117
MRQ0.445TTM0.473-0.028
TTM0.473YOY0.619-0.145
TTM0.4735Y0.742-0.269
5Y0.74210Y0.974-0.232
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets304,480,711
Total Liabilities142,694,192
Total Stockholder Equity162,798,253
 As reported
Total Liabilities 142,694,192
Total Stockholder Equity+ 162,798,253
Total Assets = 304,480,711

Assets

Total Assets304,480,711
Total Current Assets137,612,935
Long-term Assets166,867,776
Total Current Assets
Total Current Assets  (as reported)137,612,935
Total Current Assets  (calculated)0
+/- 137,612,935
Long-term Assets
Long-term Assets  (as reported)166,867,776
Long-term Assets  (calculated)0
+/- 166,867,776

Liabilities & Shareholders' Equity

Total Current Liabilities81,194,931
Long-term Liabilities61,499,261
Total Stockholder Equity162,798,253
Total Current Liabilities
Total Current Liabilities  (as reported)81,194,931
Total Current Liabilities  (calculated)0
+/- 81,194,931
Long-term Liabilities
Long-term Liabilities  (as reported)61,499,261
Long-term Liabilities  (calculated)0
+/- 61,499,261
Total Stockholder Equity
Total Stockholder Equity (as reported)162,798,253
Total Stockholder Equity (calculated)0
+/- 162,798,253
Other
Net Invested Capital 162,798,253
Net Working Capital 56,418,004



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
171,653,349
156,162,744
155,687,469
163,242,179
170,330,222
171,218,294
171,809,751
179,070,463
171,925,196
177,005,690
192,802,181
197,854,693
195,525,748
184,987,269
187,320,466
196,267,318
197,842,324
194,950,963
194,617,803
208,065,058
206,586,872
201,204,298
204,578,263
212,923,583
215,621,407
219,988,569
216,835,239
217,956,961
213,038,253
211,339,939
201,473,633
201,701,794
202,660,588
199,067,834
201,292,965
211,796,191
210,029,866
208,502,172
221,699,852
223,912,434
222,782,033
226,597,387
227,779,451
238,597,553
304,174,958
303,767,092
303,182,103
302,535,319
304,480,711
304,480,711302,535,319303,182,103303,767,092304,174,958238,597,553227,779,451226,597,387222,782,033223,912,434221,699,852208,502,172210,029,866211,796,191201,292,965199,067,834202,660,588201,701,794201,473,633211,339,939213,038,253217,956,961216,835,239219,988,569215,621,407212,923,583204,578,263201,204,298206,586,872208,065,058194,617,803194,950,963197,842,324196,267,318187,320,466184,987,269195,525,748197,854,693192,802,181177,005,690171,925,196179,070,463171,809,751171,218,294170,330,222163,242,179155,687,469156,162,744171,653,349
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,342,573
123,345,460
133,218,143
130,342,198
128,602,406
130,189,836
148,767,155
150,348,479
154,423,114
150,481,862
152,138,901
147,348,151
146,547,786
133,001,817
111,432,212
113,461,327
109,045,682
110,624,382
116,284,605
113,640,802
112,893,715
119,439,932
122,009,639
119,730,201
122,776,191
123,717,816
135,416,434
131,467,710
138,066,731
135,265,487
134,772,260
137,612,935
137,612,935134,772,260135,265,487138,066,731131,467,710135,416,434123,717,816122,776,191119,730,201122,009,639119,439,932112,893,715113,640,802116,284,605110,624,382109,045,682113,461,327111,432,212133,001,817146,547,786147,348,151152,138,901150,481,862154,423,114150,348,479148,767,155130,189,836128,602,406130,342,198133,218,143123,345,460124,342,57300000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,313,811
22,445,220
22,640,064
22,061,033
25,940,798
21,371,008
21,471,866
25,712,811
19,701,814
26,522,118
22,744,999
26,102,060
32,577,232
24,312,197
11,209,233
7,647,405
9,564,075
9,201,635
2,874,244
9,658,496
8,966,967
3,618,116
10,343,174
3,482,272
5,071,493
5,721,732
28,991,326
12,285,633
15,166,359
21,719,232
15,844,347
0
015,844,34721,719,23215,166,35912,285,63328,991,3265,721,7325,071,4933,482,27210,343,1743,618,1168,966,9679,658,4962,874,2449,201,6359,564,0757,647,40511,209,23324,312,19732,577,23226,102,06022,744,99926,522,11819,701,81425,712,81121,471,86621,371,00825,940,79822,061,03322,640,06422,445,22026,313,81100000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,842,083
12,395,726
13,237,870
17,250,902
11,155,900
12,053,367
12,942,516
13,848,125
18,759,730
19,958,331
20,896,703
0
0
47,074,199
35,823,867
38,368,056
30,570,782
32,380,568
32,559,458
23,422,326
17,372,595
23,631,390
17,873,023
22,903,153
19,743,173
21,554,266
6,455,078
6,880,590
13,468,206
10,862,248
13,894,029
0
013,894,02910,862,24813,468,2066,880,5906,455,07821,554,26619,743,17322,903,15317,873,02323,631,39017,372,59523,422,32632,559,45832,380,56830,570,78238,368,05635,823,86747,074,1990020,896,70319,958,33118,759,73013,848,12512,942,51612,053,36711,155,90017,250,90213,237,87012,395,7267,842,08300000000000000000
       Net Receivables 
39,616,592
38,959,881
34,476,474
41,712,110
43,394,292
45,568,125
48,314,138
53,244,526
52,940,566
50,463,436
51,185,727
62,805,179
52,727,146
49,073,431
46,333,407
56,853,457
58,515,428
52,516,424
54,728,152
62,351,575
52,377,341
49,724,814
57,350,150
69,200,423
62,895,824
54,936,695
41,824,458
45,809,670
39,425,541
38,279,978
37,538,304
37,737,378
37,696,923
38,578,099
37,981,248
43,380,636
43,080,324
44,655,792
47,466,576
55,596,541
48,754,203
50,771,060
57,211,858
62,131,865
66,114,567
65,963,319
57,765,595
58,722,087
0
058,722,08757,765,59565,963,31966,114,56762,131,86557,211,85850,771,06048,754,20355,596,54147,466,57644,655,79243,080,32443,380,63637,981,24838,578,09937,696,92337,737,37837,538,30438,279,97839,425,54145,809,67041,824,45854,936,69562,895,82469,200,42357,350,15049,724,81452,377,34162,351,57554,728,15252,516,42458,515,42856,853,45746,333,40749,073,43152,727,14662,805,17951,185,72750,463,43652,940,56653,244,52648,314,13845,568,12543,394,29241,712,11034,476,47438,959,88139,616,592
       Other Current Assets 
1,297,047
495,194
467,099
466,152
921,568
1,455,576
623,264
3,380,980
3,023,393
6,101,951
2,924,489
1,766,993
1,716,675
1,373,650
3,610,212
2,795,248
3,801,233
1,796,641
1,956,485
2,797,427
5,908,912
2,047,743
4,177,788
2,141,893
2,176,357
1,508,358
853,899
3,014,783
3,023,090
758,012
451,920
545,920
1,452,521
239,966
493,741
1,435,452
1,441,509
1,133,731
823,865
1,302,462
1,587,187
2,500,657
150,656
128,114
128,114
117,221
117,221
72,812
0
072,812117,221117,221128,114128,114150,6562,500,6571,587,1871,302,462823,8651,133,7311,441,5091,435,452493,741239,9661,452,521545,920451,920758,0123,023,0903,014,783853,8991,508,3582,176,3572,141,8934,177,7882,047,7435,908,9122,797,4271,956,4851,796,6413,801,2332,795,2483,610,2121,373,6501,716,6751,766,9932,924,4896,101,9513,023,3933,380,980623,2641,455,576921,568466,152467,099495,1941,297,047
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101,902,794
103,051,832
103,821,195
104,061,635
103,181,119
172,707,248
165,700,361
167,916,616
167,763,059
166,867,776
166,867,776167,763,059167,916,616165,700,361172,707,248103,181,119104,061,635103,821,195103,051,832101,902,794000000000000000000000000000000000000000
       Property Plant Equipment 
40,570,485
40,508,131
43,523,722
45,311,178
45,475,858
49,202,564
49,349,666
49,659,031
49,013,108
48,705,789
48,123,119
49,337,340
48,897,054
48,709,530
50,883,112
50,520,372
50,471,276
49,442,827
50,065,312
49,137,924
47,127,871
46,659,226
46,716,676
46,839,168
47,972,184
47,860,261
48,342,012
48,036,054
49,497,309
49,103,322
49,854,977
70,554,480
69,940,684
70,575,078
71,048,540
70,911,014
70,859,577
70,329,936
70,313,839
70,770,770
71,478,038
71,348,702
72,174,179
73,036,462
138,298,458
124,148,101
121,989,379
120,069,446
0
0120,069,446121,989,379124,148,101138,298,45873,036,46272,174,17971,348,70271,478,03870,770,77070,313,83970,329,93670,859,57770,911,01471,048,54070,575,07869,940,68470,554,48049,854,97749,103,32249,497,30948,036,05448,342,01247,860,26147,972,18446,839,16846,716,67646,659,22647,127,87149,137,92450,065,31249,442,82750,471,27650,520,37250,883,11248,709,53048,897,05449,337,34048,123,11948,705,78949,013,10849,659,03149,349,66649,202,56445,475,85845,311,17843,523,72240,508,13140,570,485
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,093,887
16,012,851
19,091,900
20,943,095
17,704,706
19,649,374
8,173,251
8,370,227
8,999,182
9,504,184
9,070,824
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000009,070,8249,504,1848,999,1828,370,2278,173,25119,649,37417,704,70620,943,09519,091,90016,012,85116,093,88700000000000000000
       Intangible Assets 
4,409,459
4,023,712
4,050,398
3,910,702
4,584,045
3,911,162
3,887,506
2,987,270
2,976,462
2,931,172
2,851,072
3,117,532
2,942,235
2,656,186
2,717,244
2,606,714
2,546,989
2,656,054
2,585,593
2,502,901
4,144,694
4,285,555
4,122,481
4,117,363
3,969,735
3,857,260
3,736,046
3,579,140
3,477,294
3,449,851
3,346,116
3,378,322
3,372,717
3,674,861
3,804,724
3,873,872
3,891,333
3,916,528
4,149,252
4,086,533
4,220,210
4,306,334
4,289,452
4,287,404
4,225,465
4,144,169
4,231,246
3,901,375
0
03,901,3754,231,2464,144,1694,225,4654,287,4044,289,4524,306,3344,220,2104,086,5334,149,2523,916,5283,891,3333,873,8723,804,7243,674,8613,372,7173,378,3223,346,1163,449,8513,477,2943,579,1403,736,0463,857,2603,969,7354,117,3634,122,4814,285,5554,144,6942,502,9012,585,5932,656,0542,546,9892,606,7142,717,2442,656,1862,942,2353,117,5322,851,0722,931,1722,976,4622,987,2703,887,5063,911,1624,584,0453,910,7024,050,3984,023,7124,409,459
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000
> Total Liabilities 
55,919,839
39,562,930
36,538,761
36,820,210
43,086,326
45,559,959
43,613,469
56,605,918
49,233,230
49,910,432
59,706,247
65,961,117
65,641,064
55,758,581
58,012,426
64,920,585
67,187,336
61,642,917
57,168,202
70,612,462
69,632,355
60,990,390
62,852,002
65,704,798
69,405,785
73,965,713
69,906,703
69,710,446
64,025,886
66,831,652
56,670,054
57,603,379
59,965,800
57,468,027
58,208,377
66,535,268
66,414,599
63,849,673
66,868,261
69,114,736
68,192,704
71,544,175
73,456,205
86,931,890
147,612,175
137,653,045
137,630,288
137,791,875
142,694,192
142,694,192137,791,875137,630,288137,653,045147,612,17586,931,89073,456,20571,544,17568,192,70469,114,73666,868,26163,849,67366,414,59966,535,26858,208,37757,468,02759,965,80057,603,37956,670,05466,831,65264,025,88669,710,44669,906,70373,965,71369,405,78565,704,79862,852,00260,990,39069,632,35570,612,46257,168,20261,642,91767,187,33664,920,58558,012,42655,758,58165,641,06465,961,11759,706,24749,910,43249,233,23056,605,91843,613,46945,559,95943,086,32636,820,21036,538,76139,562,93055,919,839
   > Total Current Liabilities 
46,691,967
30,618,051
27,319,628
27,335,173
30,596,508
32,459,908
30,090,677
42,480,722
34,790,601
34,875,153
32,949,587
38,359,461
37,789,539
28,649,564
30,720,680
51,369,176
53,922,319
48,820,065
39,776,307
58,391,130
57,251,173
48,505,559
50,287,922
52,068,001
55,162,546
59,344,492
55,346,220
56,282,378
50,603,524
53,231,260
43,463,619
44,678,365
48,791,907
43,883,941
44,543,284
52,212,214
57,164,748
53,029,930
55,829,628
61,498,455
60,520,767
63,593,675
65,105,748
78,242,413
89,073,588
78,617,053
77,612,717
77,059,153
81,194,931
81,194,93177,059,15377,612,71778,617,05389,073,58878,242,41365,105,74863,593,67560,520,76761,498,45555,829,62853,029,93057,164,74852,212,21444,543,28443,883,94148,791,90744,678,36543,463,61953,231,26050,603,52456,282,37855,346,22059,344,49255,162,54652,068,00150,287,92248,505,55957,251,17358,391,13039,776,30748,820,06553,922,31951,369,17630,720,68028,649,56437,789,53938,359,46132,949,58734,875,15334,790,60142,480,72230,090,67732,459,90830,596,50827,335,17327,319,62830,618,05146,691,967
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,435,896
409,450
1,025,700
738,030
621,890
422,430
153,380
153,380
121,030
18,000,000
18,000,000
17,400,000
17,544,720
19,900,000
19,900,000
19,866,000
19,800,000
19,600,000
19,600,000
19,600,000
19,600,000
19,450,000
19,450,000
16,850,000
20,350,000
0
0
0
0
0
0
0
000000020,350,00016,850,00019,450,00019,450,00019,600,00019,600,00019,600,00019,600,00019,800,00019,866,00019,900,00019,900,00017,544,72017,400,00018,000,00018,000,000121,030153,380153,380422,430621,890738,0301,025,700409,45024,435,89600000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,435,896
409,450
1,025,700
738,030
621,890
422,430
153,380
153,380
121,030
9,842,903
9,968,278
0
0
0
0
0
0
0
0
0
0
0
19,458,250
16,850,000
20,350,000
20,300,000
17,300,000
27,300,000
27,300,000
27,300,000
27,300,000
0
027,300,00027,300,00027,300,00027,300,00017,300,00020,300,00020,350,00016,850,00019,458,250000000000009,968,2789,842,903121,030153,380153,380422,430621,890738,0301,025,700409,45024,435,89600000000000000000
       Accounts payable 
11,186,343
9,333,535
6,863,764
9,536,888
5,130,609
12,632,121
10,853,397
15,601,656
13,813,244
13,602,270
13,049,858
16,046,981
15,948,439
8,692,318
12,627,846
17,243,379
15,694,768
11,918,041
13,744,002
17,850,463
16,702,317
12,231,824
14,616,674
12,812,901
14,655,302
9,826,018
9,769,400
10,554,845
7,556,915
7,842,090
10,227,054
9,047,874
10,065,533
7,676,779
8,336,630
0
0
11,445,282
11,214,071
12,642,869
13,763,103
13,464,203
15,117,055
15,207,848
17,025,497
14,465,876
12,343,941
10,264,944
0
010,264,94412,343,94114,465,87617,025,49715,207,84815,117,05513,464,20313,763,10312,642,86911,214,07111,445,282008,336,6307,676,77910,065,5339,047,87410,227,0547,842,0907,556,91510,554,8459,769,4009,826,01814,655,30212,812,90114,616,67412,231,82416,702,31717,850,46313,744,00211,918,04115,694,76817,243,37912,627,8468,692,31815,948,43916,046,98113,049,85813,602,27013,813,24415,601,65610,853,39712,632,1215,130,6099,536,8886,863,7649,333,53511,186,343
       Other Current Liabilities 
15,727,100
8,700,295
9,399,203
6,535,464
13,498,431
9,291,425
9,237,280
16,027,834
10,752,265
11,036,501
9,618,314
12,187,420
10,694,352
9,075,596
7,224,914
11,302,980
15,086,095
13,745,978
10,970,363
20,624,669
20,876,582
15,725,955
15,172,989
18,861,716
20,144,120
7,760,747
17,733,918
16,655,450
14,446,588
14,252,922
11,754,177
13,970,634
17,340,400
14,345,723
14,747,852
0
0
14,749,181
17,269,153
0
20,813,379
-1
0
-1
0
1
0
0
0
00010-10-120,813,379017,269,15314,749,1810014,747,85214,345,72317,340,40013,970,63411,754,17714,252,92214,446,58816,655,45017,733,9187,760,74720,144,12018,861,71615,172,98915,725,95520,876,58220,624,66910,970,36313,745,97815,086,09511,302,9807,224,9149,075,59610,694,35212,187,4209,618,31411,036,50110,752,26516,027,8349,237,2809,291,42513,498,4316,535,4649,399,2038,700,29515,727,100
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,742,724
7,778,627
8,061,746
8,350,458
8,689,478
58,538,587
59,035,991
60,017,571
60,732,722
61,499,261
61,499,26160,732,72260,017,57159,035,99158,538,5878,689,4788,350,4588,061,7467,778,6277,742,724000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
829,913
547,838
459,661
440,906
310,757
402,013
310,673
318,023
285,992
233,942
257,250
307,965
253,318
210,133
173,099
145,664
0
0
0
0
0
0
0
0000000145,664173,099210,133253,318307,965257,250233,942285,992318,023310,673402,013310,757440,906459,661547,838829,91300000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-24,435,896
-409,450
-1,025,700
-738,030
-621,890
-422,430
-153,380
-153,380
-121,030
-18,000,000
-18,000,000
-17,400,000
-17,544,720
-19,900,000
-19,900,000
-19,866,000
-19,800,000
-19,600,000
-19,600,000
-19,600,000
-19,600,000
-19,450,000
-18,903,353
-16,422,683
-20,022,851
420,948
379,412
281,019
392,847
329,951
423,880
0
0423,880329,951392,847281,019379,412420,948-20,022,851-16,422,683-18,903,353-19,450,000-19,600,000-19,600,000-19,600,000-19,600,000-19,800,000-19,866,000-19,900,000-19,900,000-17,544,720-17,400,000-18,000,000-18,000,000-121,030-153,380-153,380-422,430-621,890-738,030-1,025,700-409,450-24,435,89600000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-3
0
1
0
-1
0
0
0
000-1010-310000000000000000000000000000000000000000
> Total Stockholder Equity
114,739,790
115,592,358
117,702,322
125,888,244
126,562,212
125,072,812
127,614,101
121,728,079
122,095,466
126,596,635
132,717,113
131,062,087
129,203,359
128,556,293
128,733,327
130,892,987
130,218,768
132,886,683
137,012,268
136,958,034
136,457,357
139,765,579
141,365,164
146,766,161
145,746,558
145,460,550
146,928,536
148,246,515
149,012,367
144,508,287
144,803,580
144,098,415
142,694,788
141,599,807
143,084,588
145,260,923
143,615,267
144,652,499
154,831,591
154,797,698
154,589,329
155,053,212
154,461,562
152,086,315
157,097,796
166,600,078
166,000,088
165,675,787
162,798,253
162,798,253165,675,787166,000,088166,600,078157,097,796152,086,315154,461,562155,053,212154,589,329154,797,698154,831,591144,652,499143,615,267145,260,923143,084,588141,599,807142,694,788144,098,415144,803,580144,508,287149,012,367148,246,515146,928,536145,460,550145,746,558146,766,161141,365,164139,765,579136,457,357136,958,034137,012,268132,886,683130,218,768130,892,987128,733,327128,556,293129,203,359131,062,087132,717,113126,596,635122,095,466121,728,079127,614,101125,072,812126,562,212125,888,244117,702,322115,592,358114,739,790
   Common Stock
5,885,469
5,885,469
5,885,469
6,355,268
6,355,268
6,425,759
6,464,507
6,464,507
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
0
0
0
0
0
0
0
00000006,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,464,5076,464,5076,425,7596,355,2686,355,2685,885,4695,885,4695,885,469
   Retained Earnings 
107,489,532
107,642,665
109,614,165
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,555,598
119,672,888
119,700,588
118,856,792
122,021,152
124,608,758
129,902,606
128,887,001
127,528,073
129,007,256
130,170,214
130,959,646
126,446,691
126,738,444
126,214,828
124,814,141
123,584,491
125,031,698
127,754,389
126,501,193
127,692,997
131,569,798
133,486,572
133,671,520
134,360,547
135,030,447
131,553,064
136,848,461
146,489,468
146,079,275
145,070,017
0
0145,070,017146,079,275146,489,468136,848,461131,553,064135,030,447134,360,547133,671,520133,486,572131,569,798127,692,997126,501,193127,754,389125,031,698123,584,491124,814,141126,214,828126,738,444126,446,691130,959,646130,170,214129,007,256127,528,073128,887,001129,902,606124,608,758122,021,152118,856,792119,700,588119,672,888115,555,59800000000000000109,614,165107,642,665107,489,532
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,178,882
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
0
0
0
0
0
0
0
000000014,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,178,88200000000000000000000000000
   Treasury Stock0000000000000-4,386,985-3,951,842-3,951,842-3,951,842-3,967,048-3,951,842-3,951,842-3,951,842-3,951,842-3,951,842000-3,951,842-3,951,842-3,967,048-3,967,048-3,967,048-3,967,048-3,967,048-3,969,439-3,962,323-3,969,835-3,970,860-3,972,511-3,981,910-3,981,910-3,968,561-3,968,561-3,971,804-3,971,114-3,976,684-3,976,684-3,961,425-3,961,425-3,977,774
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180,417
423,006
330,992
674,111
817,973
-170,048
-62,899
-66,897
-34,061
1,218,287
-24,476
-48,057
-39,181
-597,916
-217,190
-220,130
-85,461
-47,887
1,218,288
1,218,288
-152,136
-149,353
4,199,488
3,806,171
1,218,288
0
0
0
0
0
0
0
00000001,218,2883,806,1714,199,488-149,353-152,1361,218,2881,218,288-47,887-85,461-220,130-217,190-597,916-39,181-48,057-24,4761,218,287-34,061-66,897-62,899-170,048817,973674,111330,992423,006180,41700000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue271,115,917
Cost of Revenue-103,219,449
Gross Profit167,896,468167,896,468
 
Operating Income (+$)
Gross Profit167,896,468
Operating Expense-264,414,542
Operating Income6,701,375-96,518,074
 
Operating Expense (+$)
Research Development13,259,497
Selling General Administrative128,821,260
Selling And Marketing Expenses0
Operating Expense264,414,542142,080,757
 
Net Interest Income (+$)
Interest Income434,518
Interest Expense-3,002,488
Other Finance Cost-0
Net Interest Income-2,567,970
 
Pretax Income (+$)
Operating Income6,701,375
Net Interest Income-2,567,970
Other Non-Operating Income Expenses0
Income Before Tax (EBT)20,239,3806,701,375
EBIT - interestExpense = -3,002,488
16,845,464
19,847,952
Interest Expense3,002,488
Earnings Before Interest and Taxes (EBIT)023,241,868
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax20,239,380
Tax Provision-3,896,200
Net Income From Continuing Ops16,343,18116,343,181
Net Income16,845,464
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,567,970
 

Technical Analysis of Ahn-gook
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ahn-gook. The general trend of Ahn-gook is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ahn-gook's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ahn-gook Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ahn-Gook Pharmaceutical Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8,140 < 8,140 < 8,280.

The bearish price targets are: 7,814 > 7,550 > 7,108.

Know someone who trades $001540? Share this with them.👇

Ahn-Gook Pharmaceutical Co. Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ahn-Gook Pharmaceutical Co. Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ahn-Gook Pharmaceutical Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ahn-Gook Pharmaceutical Co. Ltd. The current macd is 125.25.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ahn-gook price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ahn-gook. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ahn-gook price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ahn-Gook Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAhn-Gook Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ahn-Gook Pharmaceutical Co. Ltd. The current adx is 33.63.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ahn-gook shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Ahn-Gook Pharmaceutical Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ahn-Gook Pharmaceutical Co. Ltd. The current sar is 7,586.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ahn-Gook Pharmaceutical Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ahn-Gook Pharmaceutical Co. Ltd. The current rsi is 57.64. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Ahn-Gook Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) ChartAhn-Gook Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ahn-Gook Pharmaceutical Co. Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ahn-gook price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ahn-Gook Pharmaceutical Co. Ltd Daily Stochastic Oscillator ChartAhn-Gook Pharmaceutical Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ahn-Gook Pharmaceutical Co. Ltd. The current cci is 78.38.

Ahn-Gook Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) ChartAhn-Gook Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ahn-Gook Pharmaceutical Co. Ltd. The current cmo is 9.99962158.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ahn-Gook Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartAhn-Gook Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ahn-Gook Pharmaceutical Co. Ltd. The current willr is -38.35616438.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ahn-gook is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ahn-Gook Pharmaceutical Co. Ltd Daily Williams %R ChartAhn-Gook Pharmaceutical Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ahn-Gook Pharmaceutical Co. Ltd.

Ahn-Gook Pharmaceutical Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ahn-Gook Pharmaceutical Co. Ltd. The current atr is 228.25.

Ahn-Gook Pharmaceutical Co. Ltd Daily Average True Range (ATR) ChartAhn-Gook Pharmaceutical Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ahn-Gook Pharmaceutical Co. Ltd. The current obv is 21,694,679.

Ahn-Gook Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) ChartAhn-Gook Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ahn-Gook Pharmaceutical Co. Ltd. The current mfi is 52.60.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ahn-Gook Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) ChartAhn-Gook Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ahn-Gook Pharmaceutical Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Ahn-Gook Pharmaceutical Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ahn-Gook Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.644
Ma 20Greater thanMa 507,969.500
Ma 50Greater thanMa 1007,524.200
Ma 100Greater thanMa 2007,030.100
OpenGreater thanClose8,080.000
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ahn-gook with someone you think should read this too:
  • Are you bullish or bearish on Ahn-gook? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ahn-gook? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ahn-Gook Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Ahn-Gook Pharmaceutical Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Ahn-Gook Pharmaceutical Co. Ltd.

Receive notifications about Ahn-Gook Pharmaceutical Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.